Inogen (INGN) Change in Accured Expenses (2013 - 2026)
Inogen's (INGN) quarterly Change in Accured Expenses came in at -$400000.0 in Q1 2026, down 105.81% year-on-year from $6.9 million in Q1 2025, and down 2122.22% on a QoQ basis from -$18000.0 in Q4 2025.
Inogen (INGN) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Change in Accured Expenses data on file, last reported at -$400000.0 in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 105.81% year-over-year to -$400000.0 in Q1 2026; TTM through Mar 2026 was -$1.7 million, a 114.55% decrease from a year earlier, with the FY2025 full-year figure at $5.6 million, down 10.03% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$400000.0, down from -$18000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for INGN reached as high as $12.3 million in Q4 2022 and fell as low as -$6.3 million in Q2 2022.
- Historically, Change in Accured Expenses has averaged $529529.4 across 5 years, with a median of -$18000.0 in 2025.
- On a YoY basis, Change in Accured Expenses climbed as much as 441.28% in 2024 and fell as far as 6302.56% in 2024.
- Year by year, Change in Accured Expenses stood at $12.3 million in 2022, then sank by 148.94% to -$6.0 million in 2023, then surged by 252.87% to $9.2 million in 2024, then plunged by 100.2% to -$18000.0 in 2025, then tumbled by 2122.22% to -$400000.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$400000.0 in Q1 2026, -$18000.0 in Q4 2025, and $4000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Inogen | 173.63 Mn | 63.46 Mn | 37.86 Mn | -400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -400,000.00 |
| Mar 31, 2026 | -400,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | -1.28 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | 6.89 Mn |
| Mar 31, 2025 | 6.89 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 403,000.00 |
| Sep 30, 2024 | 403,000.00 |
| Jun 30, 2024 | -4.84 Mn |
| Jun 30, 2024 | -4.84 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Dec 31, 2023 | -6.00 Mn |
| Dec 31, 2023 | -6.00 Mn |